CLOVER HEALTH INVESTMENTS, CORP. /DE Revenue Breakdown
No Revenue Breakdown for CLOV on this site yet.
- 2025-12-31: Others Not split by product in the filing$1.92B100.00%; Total revenue $1.92B.
- 2024-12-31: Others Not split by product in the filing$1.37B100.00%; Total revenue $1.37B.
- 2023-12-31: Others Not split by product in the filing$1.26B100.00%; Total revenue $1.26B.
- 2022-12-31: Others Not split by product in the filing$1.10B100.00%; Total revenue $1.10B.
Source checked: the stored Revenue Breakdown page for CLOV.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $1.92B 100.00% | $1.92B |
| 2024-12-31 | Not split by product in the filing $1.37B 100.00% | $1.37B |
| 2023-12-31 | Not split by product in the filing $1.26B 100.00% | $1.26B |
| 2022-12-31 | Not split by product in the filing $1.10B 100.00% | $1.10B |
| 2021-12-31 | Not split by product in the filing $1.47B 100.00% | $1.47B |
| 2020-12-31 | Not split by product in the filing $672.89M 100.00% | $672.89M |
| 2019-12-31 | Not split by product in the filing $462.27M 100.00% | $462.27M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $743.17M 100.00% | $743.17M |
| 2026-03-31 | Not split by product $749.19M 100.00% | $749.19M |
| 2025-12-31 | Not split by product $487.71M 100.00% | $487.71M |
| 2025-09-30 | Not split by product $496.65M 100.00% | $496.65M |
| 2025-06-30 | Not split by product $477.62M 100.00% | $477.62M |
| 2025-03-31 | Not split by product $462.33M 100.00% | $462.33M |
| 2024-12-31 | Not split by product $336.96M 100.00% | $336.96M |
| 2024-09-30 | Not split by product $330.99M 100.00% | $330.99M |
| 2024-06-30 | Not split by product $356.26M 100.00% | $356.26M |
| 2024-03-31 | Not split by product $346.92M 100.00% | $346.92M |
| 2023-12-31 | Not split by product $312.38M 100.00% | $312.38M |
| 2023-09-30 | Not split by product $306.03M 100.00% | $306.03M |
| 2023-06-30 | Not split by product $320.14M 100.00% | $320.14M |
| 2023-03-31 | Not split by product $321.99M 100.00% | $321.99M |
| 2022-12-31 | Not split by product -$1.48B 100.00% | -$1.48B |
| 2022-09-30 | Not split by product $856.82M 100.00% | $856.82M |
| 2022-06-30 | Not split by product $846.70M 100.00% | $846.70M |
| 2022-03-31 | Not split by product $874.38M 100.00% | $874.38M |
| 2021-12-31 | Not split by product $432.04M 100.00% | $432.04M |
| 2021-09-30 | Not split by product $427.16M 100.00% | $427.16M |
| 2021-06-30 | Not split by product $412.47M 100.00% | $412.47M |
| 2021-03-31 | Not split by product $200.32M 100.00% | $200.32M |
| 2020-12-31 | Not split by product $166.23M 100.00% | $166.23M |
| 2020-09-30 | Not split by product $169.07M 100.00% | $169.07M |
| 2020-06-30 | Not split by product $172.08M 100.00% | $172.08M |
| 2020-03-31 | Not split by product $165.50M 100.00% | $165.50M |